Wird geladen...
Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies
Chimeric antigen receptor (CAR) T cells are patient T cells that are transduced with genetically engineered synthetic receptors to target a cancer cell surface antigen. The remarkable clinical response rates achieved by adoptive transfer of T cells that target CD19 in patients with leukemia and lymp...
Gespeichert in:
| Veröffentlicht in: | J Thorac Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738277/ https://ncbi.nlm.nih.gov/pubmed/29107016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.10.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|